surmount-2 tirzepatide type 2 diabetes weight loss results 2023 2024 Distilled: “Twincretin” significantly SURPASSes comparator effects on glucose, and quality of life surmount-2 tirzepatide type 2 diabetes

tirzepatide adds GIP (dual agonist) and retatrutide adds glucagon (triple agonist), with generally larger weight effects in trials but different tolerability profiles

Sustainable Outcomes : Semaglutide promotes healthy habits, making it easier to maintain weight loss

Signs of Compromised Medication Inspect Zepbound before each use for signs of damage or contamination

In saldo

Therefore, rising geriatric population is expected to drive the GLP-1 receptor agonist market during the forecast period

Acknowledgements This work was supported by the National Natural Science Foundation of China (82273092) to LFF and Natural Science Foundation in Zhejiang province (LD22H160003) to XW